ModifyHealth Secures $10 Million Series B Investment


ModifyHealthTM, a nationwide food as medicine platform and provider of medically adjusted meals, announces the completion of a $10 million Series B investment round headed by RC Capital and including current investor Nashville Capital Network . The collaboration with RCC will help ModifyHealth expand its nationwide operations and continue to grow its category-leading food as medicine solutions to produce meaningful patient outcomes.

ModifyHealth’s turnkey program reduces costs and improves outcomes for chronic illnesses such as type 2 diabetes, hypertension, renal disease, obesity, and irritable bowel syndrome by working directly with patients and collaborating with payors, employers, and healthcare systems.

The nutritional content, quality, and quantity of food we consume have a substantial impact on our health and wellness, according to research. Obesity and diet-related chronic illnesses continue to climb, accounting for over 75% of all health-care expenses spent in the United States.

ModifyHealth changes lives by making food as medicine simple, effective, and enjoyable for providers and patients. Along with home-delivered Low FODMAP, gluten-free, Mediterranean, plant based, and low sodium meals, ModifyHealth provides dietitian support, remote patient monitoring, and education to ensure sustained benefits.

ModifyHealth’s turnkey programs improve outcomes and cost for chronic conditions such as diabetes, heart disease, kidney disease, irritable bowel syndrome (IBS) and related issues where dietary management is a recommended treatment.

Related Stories

Latest News Stories